ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
⏸️ Investing
Broker's simple tip on picking healthcare winners in 2018
⏸️ Investing
5 shares I'd buy if I had $10,000 to invest today
⏸️ Investing
The easiest way to crush the ASX in 2018
⏸️ Investing
Why these healthcare shares could be good medicine for your portfolio
⏸️ Investing
3 healthcare blue chips I'd buy after a market tumble
⏸️ Investing
Morgans releases its "conviction buy" stocks for February
⏸️ Investing
4 more stocks hitting 52-week highs
⏸️ Investing
How the surging A$ will shape next month's reporting season
⏸️ Investing
Treasury Wine Estates Ltd hits record high but UBS is tipping more gains
⏸️ Investing
ALL ORDINARIES finishes higher Tuesday: 8 shares you missed
⏸️ Investing
Why these 4 ASX shares stormed higher today
⏸️ Investing
ResMed Inc. (CHESS) reports strong sales growth
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
